- Education
-
Research
Current research
Talent
-
Collaboration
Businesses
Government agencies and institutions
Alumni
-
About AU
Organisation
Job at AU
Associate Professor David Olagnier from Aarhus University is honoured by his peers with an EMDS Young Investigator Award. He receives the award for his promising and ambitious research into viral immunology. This work will benefit cancer and coronavirus patients, among others.
2021.07.05 |
According to Deputy Head of Department for Research Søren Riis Paludan, David Olagnier from the Department of Biomedicine is among the world's most talented young researchers in his field. Photo: Simon Byrial Fischel, AU Health.
What is the importance of our metabolism for our innate ability to deal with cancer and viral infections? And what does a possible correlation mean for our immune system's ability to fight infectious diseases? These are some of the questions that David Olagnier seeks to answer via his research.
He conducts research into new viruses such as Dengue, Zika and SARS-COV-2, and he uses genetically modified viruses to fight cancer cells in the hope of helping more patients survive forms of cancer caused by multi-resistant cancer cells.
The prize is awarded by the European Macrophage and Dendritic Cell Society (EMDS), and it acknowledges basic and hitherto unknown insight into macrophages – a group of immune cells that specialise in finding and "eating" bacteria, viruses and dead or damaged cells.
In May 2021, David Olagnier received the ACS Infectious Diseases Young Investigator Award – an American talent prize.
Associate Professor & PhD David Olagnier
Aarhus University, Department of Biomedicine
Email: olagnier@biomed.au.dk